GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy (Q42266868)

19 October 2017

GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy (English)

1 reference

19 October 2017

Hongshan Wei

1

1 reference

19 October 2017

Xiaohua Hao

2

1 reference

19 October 2017

Boan Li

3

1 reference

19 October 2017

Xingwang Li

4

1 reference

19 October 2017

Jun Hou

5

1 reference

19 October 2017

Yong Qiao

6

1 reference

19 October 2017

Renwen Zhang

7

1 reference

19 October 2017

Xin Li

8

1 reference

19 October 2017

26 September 2013

1 reference

Molecular Biology Reports

19 October 2017

1 reference

19 October 2017

40

1 reference

19 October 2017

11

1 reference

19 October 2017

6397-6405

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-013-2754-5

19 October 2017

0 references

cites work

HIV/AIDS in women: an expanding epidemic

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

The epidemic of HIV/AIDS in developing countries; the current scenario in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Laboratory operations, specimen processing, and handling for viral load testing and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Universal profiling of HIV-1 pol for genotypic study and resistance analysis across subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

The cost of providing comprehensive HIV treatment in PEPFAR-supported programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

HIV cure and eradication: how will we get from the laboratory to effective clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

GP73, a novel Golgi-localized protein upregulated by viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

GOLPH2 expression may serve as diagnostic marker in seminomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

GOLPH2 expression in renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

B lymphocyte dysfunctions in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Disease- and cell-specific expression of GP73 in human liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

21 January 2018

How to escape treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2754-5

Golgi protein 73(GP73), a useful serum marker in liver diseases

21 January 2018

1 reference

12 December 2020

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

1 reference

12 December 2020

A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma

1 reference

12 December 2020

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

1 reference

12 December 2020

Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2)

1 reference

12 December 2020

A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma

1 reference

12 December 2020

Receiver operating characteristic curves: a basic understanding

1 reference

12 December 2020

10.1007/S11033-013-2754-5

Identifiers

DOI

1 reference

19 October 2017

1 reference